CURE^® TV

With CURE TV^®, you have access to a variety of informative and uplifting videos. You’ll find interviews with cancer experts, advocates, patients, caregivers, as well as highlights from our celebratory events showcasing interviews with award winners and celebrity speakers.

Social and Economic Barriers May Affect Outcomes in Blood Cancers

July 1st 2025, 8:00pm

Video

Patients in rural or underserved areas may have worse outcomes, highlighting the need for early support to address care access barriers.

The Utility of CAR T-Cell Therapy in Myelofibrosis

July 1st 2025, 1:01pm

Video

Dr. Matthew Ku discusses what CAR T-cell therapy is and how it works to target diseases like myelofibrosis.

What is on the Horizon for Kidney Cancer?

June 30th 2025, 3:00pm

Video

Dr. Emre Yekedüz discusses how ASCO 2025 highlights precision medicine, biomarkers and the gut microbiome as keys to advancing kidney cancer care.

GIST Expert Urges Patients to Seek Specialized Second Opinions

June 30th 2025, 1:00pm

Video

Dr. Breelyn Wilky stresses the importance of expert guidance and second opinions for patients with GIST, as treatment options continue to evolve rapidly.

A Veteran Reflects on CAR T-Cell Therapy and Isolation

June 27th 2025, 8:00pm

Video

Mark Daniels, 83, credits CAR T-cell therapy and compassionate care for helping him overcome lymphoma and endure the isolating treatment toll.

Side Effects of BGB-16673 Appear Manageable in Early CLL Study

June 27th 2025, 1:00pm

Video

An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns, per Dr. Lydia Scarfò.

A Cancer Thriver Breaks Down Her Definition of Survivorship

June 26th 2025, 8:00pm

Video

Valarie Traynham shares what survivorship means to her, and how the definition has evolved after her diagnosis, during National Cancer Survivors Month.

CAR T-Cell Therapy Leads to Remission in Retired Air Force Pilot With Lymphoma

June 25th 2025, 8:00pm

Video

Dr. Andre Henri Goy shared how CAR T-cell therapy led a retired pilot with lymphoma into remission, showing the impact of personalized treatment decisions.